metronidazole and semaglutide Anti Diabetic Medicine behavior change GLP-1 analogs, new trend in

There is a potency to regain weight when taken off the drug

90 mg: -1.02%, p=0.001), BW (45 mg: -3.51%, p=0.0019

The most common side effects are gastrointestinal: nausea, vomiting, diarrhea, and constipation, particularly during the dose escalation phase when your body is adjusting to the medication

Finally, its important to note that making dietary changes to boost GLP-1 release is likely not comparable to the effectiveness of GLP-1 receptor agonist medications like semaglutide

This is potentially dangerous and we hypothesise that vulnerable patients, such as patients with eating disorders, could potentially utilise this to obtain these medications inappropriately